BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagino M, Hirano S, Yoshitomi H, Aoki T, Uesaka K, Unno M, Ebata T, Konishi M, Sano K, Shimada K, Shimizu H, Higuchi R, Wakai T, Isayama H, Okusaka T, Tsuyuguchi T, Hirooka Y, Furuse J, Maguchi H, Suzuki K, Yamazaki H, Kijima H, Yanagisawa A, Yoshida M, Yokoyama Y, Mizuno T, Endo I. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci 2021;28:26-54. [PMID: 33259690 DOI: 10.1002/jhbp.870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yamamoto R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Otsuka S, Uesaka K. Utility of remnant liver volume for predicting posthepatectomy liver failure after hepatectomy with extrahepatic bile duct resection. BJS Open 2021;5:zraa049. [PMID: 33609394 DOI: 10.1093/bjsopen/zraa049] [Reference Citation Analysis]
2 Tsutsumi C, Abe T, Kuga H, Nakamura S, Nishihara K, Tamiya S, Nakano T. Gallbladder Ciliated Foregut Cyst Suspected of Malignancy Preoperatively. Case Rep Surg 2021;2021:6222947. [PMID: 34721920 DOI: 10.1155/2021/6222947] [Reference Citation Analysis]
3 Goel M, Pandrowala S, Parel P, Patkar S. Node positivity in T1b gallbladder cancer: A high volume centre experience. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.03.013] [Reference Citation Analysis]
4 Hashimoto S, Nakaoka K, Kawabe N, Kuzuya T, Funasaka K, Nagasaka M, Nakagawa Y, Miyahara R, Shibata T, Hirooka Y. The Role of Endoscopic Ultrasound in the Diagnosis of Gallbladder Lesions. Diagnostics (Basel) 2021;11:1789. [PMID: 34679486 DOI: 10.3390/diagnostics11101789] [Reference Citation Analysis]
5 Meguro K, Hosono K, Sato M, Sugimoto Y, Takai Y, Kurita Y, Kanoshima K, Shimizu T, Sakai E, Nakajima A. Prognostic Impact of Sarcopenia in Patients With Biliary Tract Cancer Undergoing Chemotherapy. In Vivo 2021;35:2909-15. [PMID: 34410986 DOI: 10.21873/invivo.12581] [Reference Citation Analysis]
6 Isayama H, Ishii S, Tomishima K, Fujisawa T. Recent Advances in Pancreato-Biliary Endoscopic Intervention: How to Resolve Unmet Needs in Pancreato-Biliary Diseases Endoscopically. JCM 2022;11:3637. [DOI: 10.3390/jcm11133637] [Reference Citation Analysis]
7 Ueta E, Tsutsumi K, Kato H, Matsushita H, Shiraha H, Fujii M, Matsumoto K, Horiguchi S, Okada H. Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients. Sci Rep 2021;11:12298. [PMID: 34112884 DOI: 10.1038/s41598-021-91804-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kang H, Choi YS, Suh SW, Choi G, Do JH, Oh HC, Kim HJ, Lee SE. Prognostic Significance of Tumor Location in T2 Gallbladder Cancer: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:3317. [PMID: 34362101 DOI: 10.3390/jcm10153317] [Reference Citation Analysis]
9 Masuda H, Kotecha K, Maitra R, Gill AJ, Mittal A, Samra JS. Clinical suspicion of pancreatic cancer despite negative endoscopic ultrasound-guided fine-needle aspiration biopsy. ANZ J Surg 2021. [PMID: 34636123 DOI: 10.1111/ans.17256] [Reference Citation Analysis]
10 Hijioka S, Nagashio Y, Ohba A, Maruki Y, Okusaka T. The Role of EUS and EUS-FNA in Differentiating Benign and Malignant Gallbladder Lesions. Diagnostics (Basel) 2021;11:1586. [PMID: 34573929 DOI: 10.3390/diagnostics11091586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kim K, Yu JI, Jung W, Kim TH, Seong J, Kim WC, Choi JH, Park Y, Jeong BK, Kim BH, Kim TG, Kim JH, Park HJ, Shin HS, Im JH, Heo JS, Park JO, Jang JY, Oh DY, Woo SM, Lee WJ, Chie EK. Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14). Eur J Cancer 2021;157:31-9. [PMID: 34474218 DOI: 10.1016/j.ejca.2021.07.045] [Reference Citation Analysis]
12 Tanaka H, Kawashima H, Ohno E, Ishikawa T, Iida T, Ishikawa E, Furukawa K, Nakamura M, Honda T, Shimoyama Y, Miyahara R, Kawabe N, Kuzuya T, Hashimoto S, Ishigami M, Hirooka Y, Fujishiro M. Immunohistochemical staining for IMP3 in patients with duodenal papilla tumors: assessment of the potential for diagnosing endoscopic resectability and predicting prognosis. BMC Gastroenterol 2021;21:224. [PMID: 34006250 DOI: 10.1186/s12876-021-01811-8] [Reference Citation Analysis]
13 Nanashima A, Komi M, Mavar M, Ferreira C, O'Donoghue P, Goldfinger M, Langford C, Imamura N. A 3D Quantitative MRC Modeling Images Detected Case of Intrahepatic Biliary Stricture Diseases. Case Rep Gastroenterol 2021;15:680-8. [PMID: 34594166 DOI: 10.1159/000518020] [Reference Citation Analysis]
14 Kogure H, Kato H, Kawakubo K, Ishiwatari H, Katanuma A, Okabe Y, Ueki T, Ban T, Hanada K, Sugimori K, Nakai Y, Isayama H. A Prospective Multicenter Study of "Inside Stents" for Biliary Stricture: Multicenter Evolving Inside Stent Registry (MEISteR). J Clin Med 2021;10:2936. [PMID: 34208969 DOI: 10.3390/jcm10132936] [Reference Citation Analysis]
15 Inoue T, Naitoh I, Kitano R, Ibusuki M, Kobayashi Y, Sumida Y, Nakade Y, Ito K, Yoneda M. Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology 2022;29:2240-51. [DOI: 10.3390/curroncol29040182] [Reference Citation Analysis]
16 Rizzo A, Ricci AD, Cusmai A, Acquafredda S, De Palma G, Brandi G, Palmiotti G. Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the Future. Current Oncology 2022;29:551-64. [DOI: 10.3390/curroncol29020050] [Reference Citation Analysis]
17 Khankhel ZS, Goring S, Bobiak S, Lamy FX, Nayak D, Garside J, Reese ES, Schoenherr N. Second-line treatments in advanced biliary tract cancer: systematic literature review of efficacy, effectiveness and safety. Future Oncol 2022. [PMID: 35387496 DOI: 10.2217/fon-2021-1302] [Reference Citation Analysis]
18 Kitasaki N, Abe T, Oshita A, Hanada K, Noriyuki T, Nakahara M. Pyloric adenomatous carcinoma of the gallbladder following laparoscopic cholecystectomy: A case report. Int J Surg Case Rep 2021;85:106278. [PMID: 34388892 DOI: 10.1016/j.ijscr.2021.106278] [Reference Citation Analysis]
19 Oh MY, Kim H, Sohn HJ, Lee S, Lee M, Kim HS, Han Y, Kwon W, Jang JY. Long-Term Oncologic Outcomes for T2 Gallbladder Cancer According to the Type of Surgery Performed and the Optimal Timing for Sequential Extended Cholecystectomy. J Gastrointest Surg 2022. [PMID: 35641810 DOI: 10.1007/s11605-022-05368-z] [Reference Citation Analysis]
20 Matsumoto K, Okamoto K, Namura Y, Kikuyama T, Saito G, Adachi T, Watanabe A, Tsunashima H, Katsukura N, Tsujikawa T, Kikuchi K, Matsui K, Doi S. Chemotherapy with gemcitabine for unresectable intrahepatic cholangiocarcinoma in a patient undergoing maintenance hemodialysis. Clin J Gastroenterol 2021. [PMID: 34241805 DOI: 10.1007/s12328-021-01478-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Rizzo A, Cusmai A, Palmiotti G. Second-line fluoropyrimidine-based doublet chemotherapy for advanced biliary tract cancer: a new standard of care? Expert Rev Gastroenterol Hepatol 2022;16:201-3. [PMID: 35220859 DOI: 10.1080/17474124.2022.2047652] [Reference Citation Analysis]
22 Shinkawa H, Kubo S, Mikamo H, Matsuda N, Omura K, Okamoto K, Ono S, Obara H, Kobayashi M, Sasaki J, Shimizu J, Sueyoshi S, Yoshida J, Watanabe M, Takesue Y. Survey on the current status of the indication and implementation protocols for bile replacement in patients with external biliary drainage with special reference to infection control. Surg Today 2022. [PMID: 35182252 DOI: 10.1007/s00595-022-02475-x] [Reference Citation Analysis]
23 Higuchi R, Ono H, Matsuyama R, Takemura Y, Kobayashi S, Otsubo T, Abe Y, Endo I, Tanabe M, Yamamoto M; Association for Clinical Research on Surgery Group (ACRoS1406). Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406). BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02234-9] [Reference Citation Analysis]